SLC5A2 and chronic kidney disease: Statins, antiplatelet agents, renin-angiotensin system inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, lifestyle changes, and other treatments are used to slow the progression of CKD (Heerspink et al., 2018; Simeoni et al., 2021).